Département de chimie moléculaire

Cyclopeptides have been recently used successfully as carriers for the multivalent presentation of carbohydrate and peptide antigens in immunotherapy. Beside their synthetic versatility, these scaffolds are indeed interesting due to their stability against enzyme degrdn. and low immunogenicity. This mini-review highlights the recent advances in the utilization of cyclopeptides to prep. fully synthetic vaccines prototypes against cancers and pathogens. [on SciFinder(R)]